Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fragmin Safety And Efficacy In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism And Extended Thromboprophylaxis In Cancer Patients In Slovakia (An Open, Prospective, Non-Comparative Study)

NCT00480636 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00480636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00480636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fragmin Safety And Efficacy In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism And Extended Thromboprophylaxis In Cancer Patients In Slovakia (An Open, Prospective, Non-Comparative Study)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
June 30, 2007
Completion date
June 30, 2009
Enrollment
102 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute deep vein thrombosis